Physician profile
Megan E Bohrer
NPI 1265885602
$1,771.27
in general payments reported to CMS, 2019-2025
20 companies · $1,016 in 2025
The $1,016 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $249 · 2022: $59.37 · 2024: $447 · 2025: $1,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,364 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,364.03 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $403.89 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Amgen INC. | $274.96 | 2024-2025 | Otezla, Otezla, Enbrel |
| Abbvie INC. | $195.79 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $173.41 | 2024-2025 | |
| Organon LLC | $105.04 | 2025 | |
| Novartis Pharmaceuticals Corporation | $98.84 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.28 | 2024-2025 | Spevigo, Cyltezo |
| Regeneron Healthcare Solutions, INC. | $68.98 | 2021-2025 | Dupixent |
| Genzyme Corporation | $66.38 | 2025 | |
| Biofrontera INC. | $39.72 | 2024-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Arcutis Biotherapeutics, INC. | $35.71 | 2024-2025 | Zoryve |
| Incyte Corporation | $35.24 | 2024 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $34.93 | 2025 | Sotyktu |
| Lilly USA, LLC | $34.41 | 2021-2025 | Ebglyss |
| Pfizer INC. | $29.12 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $24.82 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.69 | 2024 | Siliq |
| Kyowa Kirin, INC. | $18.24 | 2025 | |
| Mayne Pharma Commercial LLC | $16.78 | 2025 | |
| Pharmacosmos Therapeutics INC. | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Bohrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.